Biological Implications and Broader-Range Functions for APOBEC-1 and APOBEC-1 Complementation Factor (ACF)

RNA and DNA Editing: Molecular Mechanisms and Their Integration into Biological Systems

Volumn , Issue , 2007, Pages 203-230

  Blanc, Valerie ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apobec 1 complementation factor(ACF); Base modification RNA editing; Biochemical and genetic mechanisms

Indexed keywords

EID: 84889390522     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470262269.ch10     Document Type: Chapter

References (105)

1. Maas, S., and Rich, A. (2000) Changing genetic information through RNA editing. Bioessays 22, 790-802.
2. Blanc, V., and Davidson, N. O. (2003) C-to-U RNA editing: Mechanisms leading to genetic diversity. J Biol Chem 278, 1395-1398.
3. Mehta, A., Kinter, M. T., Sherman, N. E., and Driscoll, D. M. (2000) Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 20, 1846-1854.
4. Lellek, H., Kirsten, R., Diehl, I., Apostel, F., Buck, F., and Greeve, J. (2000) Purification and molecular cloning of a novel essential component of the apolipoproteinBmRNAediting enzyme-complex. J Biol Chem 275, 19848-19856.
5. Davidson, N. O., and Shelness, G. S. (2000) APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 20, 169-193.
6. Greeve, J., Altkemper, I., Dieterich, J. H., Greten, H., andWindler, E. (1993) ApolipoproteinBmRNA editing in 12 different mammalian species: Hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 34, 1367-1383.
7. Hadjiagapiou, C., Giannoni, F., Funahashi, T., Skarosi, S. F., and Davidson, N. O. (1994) Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein. Nucleic Acids Res 22, 1874-1879.
8. Lau, P. P., Zhu, H. J., Baldini, A., Charnsangavej, C., and Chan, L. (1994) Dimeric structure of ahuman apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci USA 91, 8522-8526.
9. Teng, B., Black, D. D.,andDavidson, N. O. (1990) ApolipoproteinBmessengerRNAeditingisdevelopmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. Biochem Biophys Res Commun 173, 74-80.
10. Young, S. G. (1990) Recent progress in understanding apolipoprotein B. Circulation 82, 1574-1594.
11. Shah, R. R., Knott, T. J., Legros, J. E., Navaratnam, N., Greeve, J. C., and Scott, J. (1991) Sequence requirements for the editing of apolipoprotein B mRNA. J Biol Chem 266, 16301-16304.
12. Backus, J. W., and Smith, H. C. (1992) Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro. Nucleic Acids Res 20, 6007-6014.
13. Hersberger, M., Patarroyo-White, S., Arnold, K. S., and Innerarity, T. L. (1999) Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 30 efficiency element. J Biol Chem 274, 34590-34597.
14. Richardson, N., Navaratnam, N., and Scott, J. (1998) Secondary structure for the apolipoprotein B mRNA editing site. AU-binding proteins interact with a stem loop. J Biol Chem 274, 31707-31717.
15. Davidson, N. O. (2002) The challenge of target sequence specificity in C!U RNA editing. J Clin Invest 109, 291-294.
16. Hersberger, M., and Innerarity, T. L. (1998) Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J Biol Chem 273, 9435-9442.
17. Teng, B., Burant, C. F., andDavidson, N. O. (1993) Molecular cloning ofan apolipoproteinBmessenger RNA editing protein. Science 260, 1816-1819.
18. Giannoni, F., Bonen, D. K., Funahashi, T., Hadjiagapiou, C., Burant, C. F., andDavidson, N. O. (1994) Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem 269, 5932-5936.
19. Navaratnam, N., Fujino, T., Bayliss, J., Jarmuz, A., How, A., Richardson, N., Somasekaram, A., Bhattacharya, S., Carter, C., and Scott, J. (1998) Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. J Mol Biol 275, 695-714.
20. Teng, B., Ochsner, S., Zhang, Q., Soman, K. V., Lau, P. P., and Chan, L. (1999) Mutational analysis of apolipoproteinBmRNAediting enzyme (Apobec-1): Structure-function relationships ofRNAediting and dimerization. J Lipid Res 40, 623-635.
21. Oka, K., Kobayashi, K., Sullivan, M., Martinez, J., Teng, B. B., Ishimura-Oka, K., and Chan, L. (1997) Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased lowdensity lipoprotein in mice. J Biol Chem 272, 1456-1460.
22. Navaratnam, N., Morrison, J. R., Bhattacharya, S., Patel, D., Funahashi, T., Giannoni, F., Teng, B. B., Davidson, N. O., and Scott, J. (1993) The p27 catalytic subunit of the apolipoprotein BmRNAediting enzyme is a cytidine deaminase. J Biol Chem 268, 20709-20712.
23. Teng, B., andDavidson, N. O. (1992) Evolution of intestinal apolipoproteinBmRNAediting. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J Biol Chem 267, 21265-21272.
24. Henderson, J. O., Blanc, V., andDavidson, N. O. (2001) Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim Biophys Acta 1522, 22-30.
25. Blanc, V., Henderson, J. O., Newberry, E. P., Kennedy, S., Luo, J., andDavidson, N. O. (2005) Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality. Mol Cell Biol 25, 7260-7269.
26. Harris, S. G., Sabio, I., Mayer, E., Steinberg, M. F., Backus, J. W., Sparks, J. D., Sparks, C. E., and Smith, H. C. (1993) Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins. J Biol Chem 268, 7382-7392.
27. Blanc, V., Henderson, J. O., Kennedy, S., and Davidson, N. O. (2001) Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation ofCtoURNA-editing activity. J BiolChem 276, 46386-46393.
28. Schock, D., Kuo, S. R., Steinburg, M. F., Bolognino, M., Sparks, J. D., Sparks, C. E., and Smith, H. C. (1996) Anauxiliary factor containing a 240-kDa protein complex is involved in apolipoproteinBRNA editing. Proc Natl Acad Sci USA 93, 1097-10102.
29. Markovtsov, V., Nikolic, J. M., Goldman, J. A., Turck, C. W., Chou, M. Y., and Black, D. L. (2000) Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol 20, 7463-7479.
30. Rossoll, W., Kroning, A. K., Ohndorf, U. M., Steegborn, C., Jablonka, S., and Sendtner, M. (2002) Spec-ific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: A role for Smn in RNA processing in motor axons? Hum Mol Genet 11, 93-105.
31. Lau, P. P., Xiong, W. J., Zhu, H. J., Chen, S. H., and Chan, L. (1991) ApolipoproteinBmRNAediting is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J Biol Chem 266, 20550-20554.
32. Mourelatos, Z., Abel, L., Yong, J., Kataoka, N., and Dreyfuss, G. (2001) SMN interacts with a novel family of hnRNP and spliceosomal proteins. Embo J 20, 5443-5452.
33. Anant, S., Henderson, J. O., Mukhopadhyay, D., Navaratnam, N., Kennedy, S., Min, J., and Davidson, N. O. (2001) Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem 276, 47338-47351.
34. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
35. Harris, R. S.,andLiddament, M. T. (2004) Retroviral restrictionbyAPOBECproteins. NatRevImmunol 4, 868-877.
36. Yang, Y., Yang, Y., and Smith, H. C. (1997) Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing. Proc Natl Acad Sci USA 94, 13075-13080.
37. Chester, A., Somasekaram, A., Tzimina, M., Jarmuz, A., Gisbourne, J., O'Keefe, R., Scott, J., and Navaratnam, N. (2003) TheapolipoproteinBmRNAediting complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J 22, 3971-3982.
38. Yang, Y., Sowden, M. P., Yang, Y., and Smith, H. C. (2001) Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein BmRNA. Exp Cell Res 267, 153-164.
39. Giannoni, F., Chou, S. C., Skarosi, S. F., Verp, M. S., Field, F. J., Coleman, R. A., and Davidson, N. O. (1995) Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine. J Lipid Res 36, 1664-1675.
40. Navaratnam, N., Bhattacharya, S., Fujino, T., Patel, D., Jarmuz, A. L., and Scott, J. (1995) Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNAbinding motif at its active site. Cell 81, 187-195.
41. MacGinnitie, A. J., Anant, S., and Davidson, N. O. (1995) Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem 270, 14768-14775.
42. Anant, S., MacGinnitie, A. J.,and Davidson, N. O.(1995) apobec-1, the catalyticsubunit of themammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 270, 14762-14767.
43. Xie, K., Sowden, M. P., Dance, G. S., Torelli, A. T., Smith, H. C., andWedekind, J. E. (2004) The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. Proc Natl Acad Sci USA 101, 8114-8119.
44. Maris, C., Masse, J., Chester, A., Navaratnam, N., and Allain, F. H. (2005) NMRstructure of the apoB mRNA stem-loop and its interaction with the C-to-U editing APOBEC1 complementary factor. RNA 11, 173-186.
45. Anant, S., and Davidson, N. O. (2000) AnAU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: Binding of Apobec-1 to this motif in the 30 untranslated region of c-myc increasesmRNAstability. Mol Cell Biol 20, 1982-1992.
46. Barreau, C., Paillard, L., and Osborne, H. B. (2005) AU-rich elements and associated factors: Are there unifying principles? Nucleic Acids Res 33, 7138-7150.
47. Navaratnam, N., Patel, D., Shah, R. R., Greeve, J. C., Powell, L. M., Knott, T. J., and Scott, J. (1991) An additional editing site is present in apolipoprotein B mRNA. Nucleic Acids Res 19, 1741-1744.
48. Skuse, G. R., Cappione, A. J., Sowden, M., Metheny, L. J., andSmith, H. C. (1996) The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res 24, 478-485.
49. Mukhopadhyay, D., Anant, S., Lee, R. M., Kennedy, S., Viskochil, D., and Davidson, N. O. (2002) C!U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein BmRNA-editing enzyme. Am J Hum Genet 70, 38-50.
50. Sowden, M. P., Ballatori, N., Jensen, K. L., Reed, L. H., and Smith, H. C. (2002) The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. J Cell Sci 115, 1027-1039.
51. Baum, C. L., Teng, B. B., and Davidson, N. O. (1990) ApolipoproteinBmessengerRNAediting in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem 265, 19263-19270.
52. Inui, Y., Giannoni, F., Funahashi, T., andDavidson, N. O. (1994)REPRand complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. J Lipid Res. 35, 1477-1489.
53. Cho, S. J., Blanc, V., andDavidson, N. O. (2007) Mousemodels as tools to exploreCtoURNAediting. Meth Enzymol 424, 417-435.
54. Sowden, M., Hamm, J. K., and Smith, H. C. (1996) Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem 271, 3011-3017.
55. Hersberger, M., Patarroyo-White, S., Qian, X., Arnold, K. S., Rohrer, L., Balestra, M. E., and Innerarity, T. L. (2003) Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. Biochem J 369, 255-262.
56. Yamanaka, S., Poksay, K. S., Driscoll, D. M., and Innerarity, T. L. (1996) Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem 271, 11506-11510.
57. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M., and Innerarity, T. L. (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 92, 8483-8487.
58. Yamanaka, S., Poksay, K. S., Arnold, K. S., and Innerarity, T. L. (1997)Anovel translational repressor mRNAis edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev 11, 321-333.
59. Fukuchi-Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., Ekimoto, H., and Igarashi, K. (1997) Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57, 5041-5044.
60. Hirano, K., Young, S. G., Farese, R.V., Jr., Ng, J., Sande, E., Warburton, C., Powell-Braxton, L. M., and Davidson, N. O. (1996) Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 271, 9887-9890.
61. Morrison, J. R., Paszty, C., Stevens, M. E., Hughes, S. D., Forte, T., Scott, J., and Rubin, E. M. (1996) Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA 93, 7154-7159.
62. Kendrick, J. S., Chan, L., and Higgins, J. A. (2001) Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: An investigation of apobec-1 knock-out and wild-type mice. Biochem J 356, 821-827.
63. Xie, Y., Nassir, F., Luo, J., Buhman, K., and Davidson, N. O. (2003) Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. Am J Physiol Gastrointest Liver Physiol 285, G735-G746.
64. Powell-Braxton, L., Veniant, M., Latvala, R. D., Hirano, K. I., Won, W. B., Ross, J., Dybdal, N., Zlot, C. H., Young, S. G., and Davidson, N. O. (1998) A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med 4, 934-938.
65. Mehta, A., and Driscoll, D. M. (2002) Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing. RNA 8, 69-82.
66. Burd, C. G., and Dreyfuss, G. (1994) Conserved structures and diversity of functions of RNA-binding proteins. Science 265, 615-621.
67. Sowden, M. P., Lehmann, D. M., Lin, X., Smith, C. O., and Smith, H. C. (2004) Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing. J Biol Chem 279, 197-206.
68. Chen, Z., Eggerman, T. L., and Patterson, A. P. (2007) ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components. Am J Physiol Gastrointest Liver Physiol 292, G53-G65.
69. Linden, D., Sjoberg, A., Asp, L., Carlsson, L., and Oscarsson, J. (2000) Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes. Am J Physiol Endocrinol Metab 279, E1335-E1346.
70. Funahashi, T., Giannoni, F., DePaoli, A. M., Skarosi, S. F., andDavidson, N. O. (1995)Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: Functional role in the modulation of apoB mRNA editing. J Lipid Res 36, 414-428.
71. Giangreco, A., Sowden, M. P., Mikityansky, I., and Smith, H. C. (2001) Ethanol stimulates apolipoprotein B mRNA editing in the absence of de novo RNA or protein synthesis. Biochem Biophys Res Commun 289, 1162-1167.
72. Lehmann, D. M., Galloway, C. A., Sowden, M. P., and Smith, H. C. (2006)Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res 34, 3299-3308.
73. VanMater, D., Sowden, M. P., Cianci, J., Sparks, J. D., Sparks, C. E., Ballatori, N., and Smith, H. C. (1998) Ethanol increases apolipoprotein B mRNA editing in rat primary hepatocytes and McArdle cells. Biochem Biophys Res Commun 252, 334-339.
74. Lehmann, D. M., Galloway, C. A., MacElrevey, C., Sowden, M. P., Wedekind, J. E., and Smith, H. C. (2007) Functional characterization of APOBEC-1 complementation factor phosphorylation sites. Biochim Biophys Acta 1773, 408-418.
75. Mukhopadhyay, D., Houchen, C.W., Kennedy, S., Dieckgraefe, B. K., and Anant, S. (2003) Coupled mRNAstabilization and translational silencing of cyclooxygenase-2 by a novelRNAbinding protein, CUGBP2. Mol Cell 11, 113-126.
76. Lau, P. P., Cahill, D. J., Zhu, H. J., and Chan, L. (1995) Ethanol modulates apolipoprotein B mRNA editing in the rat. J Lipid Res 36, 2069-2078.
77. Conne, B., Stutz, A., andVassalli, J. D. (2000) The 30 untranslated region of messengerRNA:Amolecular 'hotspot' for pathology? Nat Med 6, 637-641.
78. Chen, C. Y. and Shyu, A. B. (1995) AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20, 465-470.
79. Herschman, H. R. (1991) Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60, 281-319.
80. Espel, E., Garcia-Sanz, J. A., Aubert, V., Menoud, V., Sperisen, P., Fernandez, N., and Spertini, F. (1996)Transcriptional and translational control of TNF-alpha gene expression inhumanmonocytes by major histocompatibility complex class II ligands. Eur J Immunol 26, 2417-2424.
81. Audic, Y., and Hartley, R. S. (2004) Post-transcriptional regulation in cancer. Biol Cell 96, 479-498.
82. Anant, S., Murmu, N., Houchen, C. W., Mukhopadhyay, D., Riehl, T. E., Young, S. G., Morrison, A. R., Stenson, W. F., and Davidson, N. O. (2004) Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127, 1139-1149.
83. Riehl, T., Cohn, S., Tessner, T., Schloemann, S., and Stenson, W. F. (2000) Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 118, 1106-1116.
84. Gou, Q., Liu, C. H., Ben-Av, P., and Hla, T. (1998) Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 30-untranslated region. Biochem Biophys Res Commun 242, 508-512.
85. Cok, S. J., andMorrison, A. R. (2001) The 30-untranslated region ofmurine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276, 23179-23185.
86. Stenson, W. F. (2007) Prostaglandins and epithelial response to injury. Curr Opin Gastroenterol 23, 107-110.
87. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188.
88. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110, 1259-1262.
89. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111, 1134-1140.
90. Blanc, V., Henderson, J. O., Cho, S., Newberry, R. D., Xie, Y., Newberry, E. P., Rubin, D. C., Wang, H. L., Luo, J., Kennedy, S., and Davidson, N. O. (2007) Deletion of the AU-rich RNA binding protein apobec-1 reduces intestinal tumor burden in APCmin mice. Cancer Res. 67, 8565-8573.
91. Yamanaka, S., Zhang, X.Y., Maeda, M., Miura, K., Wang, S., Farese, R.V., Jr., Iwao, H., and Innerarity, T. L. (2000) Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J 19, 5533-5541.
92. Rothstein, J. L., Johnson, D., DeLoia, J. A., Skowronski, J., Solter, D., and Knowles, B. (1992) Gene expression during preimplantation mouse development. Genes Dev 6, 1190-1201.
93. Taub, R. (2004) Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 5, 836-847.
94. Verna, L., Whysner, J., andWilliams, G. M. (1996) N-nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71, 57-81.
95. Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J. P., Rath, M., andWagner, E. F. (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192.
96. Dalmau, J., Furneaux, H. M., Gralla, R. J., Kris, M. G., and Posner, J. B. (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-aquantitative western blot analysis. Ann Neurol 27, 544-552.
97. Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J. B., and Furneaux, H. M. (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67, 325-333.
98. Brennan, C. M., and Steitz, J. A. (2001) HuR and mRNA stability. Cell Mol Life Sci 58, 266-277.
99. Fan, X. C., and Steitz, J. A. (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 95, 15293-15298.
100. Wang, W., Caldwell, M. C., Lin, S., Furneaux, H., and Gorospe, M. (2000)HuRregulates cyclinAand cyclin B1 mRNA stability during cell proliferation. EMBO J 19, 2340-2350.
101. Wang, W., Yang, X., Cristofalo, V. J., Holbrook, N. J., and Gorospe, M. (2001) Loss ofHuRis linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21, 5889-5898.
102. Dixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108, 1657-1665.
103. Raineri, I., Wegmueller, D., Gross, B., Certa, U., and Moroni, C. (2004) Roles ofAUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res 32, 1279-1288.
104. Denkert, C., Weichert, W., Pest, S., Koch, I., Licht, D., Kobel, M., Reles, A., Sehouli, J., Dietel, M., and Hauptmann, S. (2004) Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64, 189-195.
105. Blaxall, B. C., Dwyer-Nield, L. D., Bauer, A. K., Bohlmeyer, T. J., Malkinson, A. M. and Port, J. D. (2000) Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28, 76-83.